Elutia (ELUT) EBT Growth (1y) (2020 - 2026)
Elutia (ELUT) EBT Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 17.94% |
| 10 | Elutia | 40.75 Mn | 20.85 Mn | 1.45 Mn | -7.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -316.39% |
| Dec 31, 2025 | 8.84% |
| Sep 30, 2025 | -111.20% |
| Jun 30, 2025 | 66.16% |
| Mar 31, 2025 | 89.55% |
| Dec 31, 2024 | 53.03% |
| Sep 30, 2024 | 139.34% |
| Jun 30, 2024 | -267.60% |
| Mar 31, 2024 | -84.11% |
| Dec 31, 2023 | -153.12% |
| Sep 30, 2023 | 22.78% |
| Jun 30, 2023 | 17.77% |
| Mar 31, 2023 | -20.06% |
| Dec 31, 2022 | 33.53% |
| Sep 30, 2022 | -32.67% |
| Jun 30, 2022 | -296.54% |
| Mar 31, 2022 | -61.00% |
| Dec 31, 2021 | -69.26% |
| Sep 30, 2021 | -23.52% |
| Jun 30, 2021 | 54.24% |